Evaluation of patients with increased fibrinolytic split products (FSP) in their serum.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001772:Blood Cell Count; D001779:Blood Coagulation Factors / Q000032:analysis*; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D002648:Child; D003095:Collagen Diseases / Q000097:blood; D004211:Disseminated Intravascular Coagulation / Q000097:blood* / Q000145:classification; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006801:Humans; D007239:Infections / Q000097:blood; D007674:Kidney Diseases / Q000097:blood; D007938:Leukemia / Q000097:blood; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood; D011517:Prothrombin Time; D013917:Thrombin / Q000032:analysis; D014652:Vascular Diseases / Q000097:blood
D001779:Blood Coagulation Factors; D005340:Fibrinogen; D013917:Thrombin